Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

Jakko van Ingen, Timothy Aksamit, Claire Andrejak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won-Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin L. Winthrop, Dirk Wagner

Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jakko van Ingen, Timothy Aksamit, Claire Andrejak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won-Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin L. Winthrop, Dirk Wagner. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Guideline 2020
Year: 2020

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Year: 2020



Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018
Year: 2019



Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease
Source: Eur Respir Monogr 2018; 81: 204-221
Year: 2018


New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Source: Virtual Congress 2020 – German programme 2020
Year: 2020


Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019
Year: 2020



The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016
Year: 2017


Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019


Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
Source: Eur Respir J, 49 (6) 1700051; 10.1183/13993003.00051-2017
Year: 2017



New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Year: 2020


Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Patient reported outcomes for non-tuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019
Year: 2020



Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018


Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009